We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dotdigital Group Plc | LSE:DOTD | London | Ordinary Share | GB00B3W40C23 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.60 | 2.86% | 93.60 | 89.20 | 90.90 | 92.50 | 89.10 | 89.10 | 96,487 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Related Svcs, Nec | 69.23M | 12.6M | 0.0412 | 21.77 | 278.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/9/2024 16:55 | The US venture funds have a clear strategy of waiting for trouble and then buying up at knockdown prices. That happened after Brexit and especially after Covid and recently with interest rates causing problems for businesses with debt. The business has to be attractive as an ARR business or cheap from an asset point of view, or a potential competitor though. Not sure DOTD has enough traction to be an ARR target or a competitor for any US business. No assets like Morrisons, so can't be bought for the price of the property with the business thrown in for free. | yump | |
22/8/2024 12:03 | Does seem that the better smaller companies get bought out whilst the weaker ones go to the wall, or increasingly seem likely to delist as they reckon it’s easier to raise capital as a private company. Whether that’s actually true I’m not sure. But I remain a holder hoping that these will eventually appreciate | dr biotech | |
22/8/2024 11:54 | The trading update at the end of last month was reassuring but did little to encourage the share price which continues to flounder in its long-tailed post-covid malaise. Various other similar small companies have been swallowed by private equity or other predators (mainly US) which has become one of the reasons for buying/holding them. Not that the proceeds have been notably generous but at least it tends to produce fair value with little or no premium. So I continue to hold in the hope that the market will attribute a better value or that someone else will do so. Since Jan 2023 I have 'lost' seven companies in this way, typically by agreed scheme of arrangement, with another two now under negotiation. Rather sad really. I note that pre-covid the results were typically released in mid-October but, having slipped understandably to mid-November in 2020, they have never recovered. The company could do itself a good turn by looking a little sharper this year! | boadicea | |
10/4/2024 13:37 | Good to see a better tone in the market for DOTD since the start of the new tax year after the disappointing response to an encouraging interim report. This remains on my growing list of what I consider to be undervalued prospects and I expect a better response from the next trading update, normally not before July unfortunately - unless they can find a suitable opportunity to confirm progress at an earlier date which would be a valued bonus. | boadicea | |
12/3/2024 07:15 | First half 2024 earnings released: EPS: UK£0.02 (vs UK£0.022 in 1H 2023)First half 2024 results:EPS: UK£0.02 (down from UK£0.022 in 1H 2023).Revenue: UK£38.7m (up 15% from 1H 2023).Net income: UK£6.04m (down 6.9% from 1H 2023).Profit margin: 16% (down from 19% in 1H 2023). The decrease in margin was driven by higher expenses. | muffster | |
05/3/2024 08:30 | Excellent results | bprofit | |
08/1/2024 16:41 | Should find out how Fresh Relevance is doing. Earnings enhancing 2025 so not really expecting fireworks. Nice steady progress will do. | yump | |
08/1/2024 14:23 | xd this Thursday. Trading update in a couple of weeks. It could be time to break out of the trading range. | jurgenklopp | |
29/11/2023 17:10 | Interesting bounce today on not much volume. | yump | |
22/11/2023 15:28 | Well this is not much help because I can’t recall the business, but found a p/e of about 40 last week on a business with 95% ish recurring revenues while looking for growth stocks. I think it was financial software. So perhaps this will get back someway to previous rating. | yump | |
22/11/2023 14:35 | added to my position here today, alot of potential this one like Good Energy | oldboy1 | |
22/11/2023 08:13 | Decent FY results announced a fortnight ago, and decent cash balance after the acquisition of Fresh Relevance, hence the rally in the price: Dotdigital Group plc (AIM: DOTD), the leading SaaS provider of an all-in-one customer experience and data platform (CXDP), announces its final audited results for the year ended 30 June 2023 ("FY23"). Financial Highlights -- Group revenue growth of 10% to GBP69.2m (FY22: GBP62.8m) o Recurring and repeating revenue was maintained at 94% of total revenue (FY22: 94%). Contracted recurring revenue continues to represent 79% of total revenue o ARPC(1) increased 11% to GBP1,622 per month (FY22: GBP1,461 per month) o ARR(2) growth of 10% to GBP54.4m (FY22: 10%) -- Adjusted EBITDA(3) of GBP22.0m (FY22: GBP21.7m) and adjusted operating profit of GBP14.5m (FY22: GBP14.5m) -- Adjusted profit before tax(4) of GBP15.4m (FY22: GBP14.5m) -- Adjusted diluted earnings per share increased 6% to 4.43p (FY22: 4.18p) -- Strong net cash balance on 30 June 2023 of GBP52.7m (30 June 2022: GBP43.9m) -- Proposed final dividend of 1p per ordinary share (FY22: 0.98p) in line with progressive dividend policy | strollingmolby | |
22/11/2023 07:35 | New SCSWatcher thread now has 28 followers which is great. Be good to get around 40 regulars on there ahead of 2024 Please save the thread in your favourites and like it at the top of the thread so we can keep a tab on numbers. | john09 | |
14/11/2023 16:40 | excuse the earlier typo, very bullish. Expecting all small caps to recover nicely. Pockets of carefully selected stocks and a few of SCSW recomendations being doing that over the last month aswell, good, DOT, BOWL, and few others, even the big bank caps responding. This latest inflation news will propell everything. If the NASDAQ carries on it's tear, EVERYTHING else will. This is a great day for shareholders for sure | oldboy1 | |
14/11/2023 14:25 | UK markets up, US pre market up, bulls are out in force chaps! | oldboy1 | |
14/11/2023 14:10 | absolutely glorious news on inflation. Great for everyone holding stocks! fingers crossed that this is a beginning of a nice bear market | oldboy1 | |
14/11/2023 12:04 | not a bad start to the day either. | oldboy1 | |
14/11/2023 09:09 | Yump tend to agree with that. I'm in this one and intend to hold long term, which I believe will reward patient shareholders. | oldboy1 | |
13/11/2023 12:40 | I'm holding these after buying late last year, but imo it will need something significant to get it over 100p, as that is around a p/e of 20. Its fallen a long way but the peaks were giving it a massive rating. All depends what rating this level of recurring revenue is worth really. Sit on hands, have a look in 2 yrs I reckon. Some stocks just grow reliably with no sparks. | yump | |
13/11/2023 12:01 | fantastic returns on this and a few SCSW recomdations lately, still a long way to go. Good Enery worth a look too, not too late to get in on that one imo, due your own due dilligence. | oldboy1 | |
07/11/2023 13:13 | nice to see this waking up over last few days. Another strong SCSW recommendation ! | oldboy1 | |
03/11/2023 14:20 | It looks like the overhang is cleared. At least for now. | nhb001 | |
25/10/2023 17:26 | They certainly owned c5% a couple of years ago | dr biotech | |
25/10/2023 08:34 | That is what the RNS implies but my Stockopedia dashboard says Slater Investments already owned 5.27%. However (!), the institutional ownership data on Stockopedia can sometimes be inaccurate. Hence my confusion. :-) | nhb001 | |
25/10/2023 07:57 | An increase from zero, if the RNS is correct. | nocton |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions